- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Nusinersen – July 2018
Nusinersen: Solution for injection 12 mg in 5 mL; Spinraza®
Last updated
26 October 2018